What Analysts Are Saying About Elevance Health Stock
Portfolio Pulse from Benzinga Insights
Analysts have provided a range of ratings for Elevance Health (NYSE:ELV) over the past three months, with most being somewhat bullish. The average 12-month price target is $607.47, slightly down from previous estimates. Despite a slight revenue decline, Elevance Health shows strong financial performance with high net margins and ROE. However, it faces challenges in debt management.
August 19, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Elevance Health has received mixed analyst ratings, with a majority being somewhat bullish. The average price target is slightly down, indicating cautious optimism. Despite a small revenue decline, the company maintains strong financial metrics but faces challenges in debt management.
The article provides a detailed analysis of analyst ratings for Elevance Health, showing a mix of bullish and somewhat bullish sentiments. The average price target has slightly decreased, reflecting cautious optimism. Despite a minor revenue decline, Elevance Health's strong net margin and ROE indicate solid financial health. However, the high debt-to-equity ratio suggests potential financial strain, balancing the overall impact to neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100